{
  "id": "a2ad16e9500cdd63",
  "title": "Pilatus Biosciences Inc .: Pilatus Biosciences Receives FDA Fast Track Designation for Metabolic Checkpoint Inhibitor PLT012 in Hepatocellular Carcinoma",
  "description": "20260219T133000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67741210-pilatus-biosciences-inc-pilatus-biosciences-receives-fda-fast-track-designation-for-metabolic-checkpoint-inhibitor-plt012-in-hepatocellular-carcinom-004.htm",
  "published_at": "20260219T133000Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67741210-pilatus-biosciences-inc-pilatus-biosciences-receives-fda-fast-track-designation-for-metabolic-checkpoint-inhibitor-plt012-in-hepatocellular-carcinom-004.htm",
    "url_mobile": "",
    "title": "Pilatus Biosciences Inc .: Pilatus Biosciences Receives FDA Fast Track Designation for Metabolic Checkpoint Inhibitor PLT012 in Hepatocellular Carcinoma",
    "seendate": "20260219T133000Z",
    "socialimage": "https://cts.businesswire.com/ct/CT?id=bwnews&sty=20260219271062r1&sid=gefi2&distro=ftp",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}